Global Breast Cancer Market Report: 2015 Edition - New Report by Koncept Analytics

1
Global Breast Cancer Market Report
----------------------------------------- 2015
View Report Details
2
View Report Details

• Executive Summary
• Breast cancer is the most commonly diagnosed
  cancer and the leading cause of cancer deaths in
  women. Breast cancer knows considers no
  boundaries of age, gender, socioeconomic status
  or geographic location. Being a woman and growing
  older are the factors which associate maximum
  risk of having breast cancer.
• In the past few years, the cases of breast cancer
  have increased tremendously in certain regions
  including the U.S. and the Europe. The breast
  cancer market is driven by various factors
  including aging female population, obesity and
  diabetes, dense breast tissues, healthcare
  expenditure, exposure to X-Ray and Gamma
  Radiations, Estrogen-Progestin Therapy (EPT) and
  increased consumption of alcohol and tobacco. A
  major trend which will probably remain prominent
  in the breast cancer treatment industry is the
  fact that innovative technologies and
  pharmaceutical molecules are always under
  development and are mostly subject to changes.
  Challenges associated with breast cancer are
  like, financial burdens associated with the
  treatment and adverse effects of Aromatase
  Inhibitors (AI) on patients.
• The market for breast cancer drugs represents an
  area of potential opportunity in both developed
  and developing countries. Due to effectiveness
  and advancements in technology, a large number of
  companies are focusing to develop innovative
  breast cancer drugs and treatments. Further, the
  companies are combining businesses and spending
  heavily on research and development to develop
  effective treatment methods for breast cancer.
• The present report provides a comprehensive
  analysis of the global breast cancer diagnosis
  and treatment market with focus on regions like
  the US, Brazil, Europe and APAC Countries.
  Furthermore, market dynamics such as the industry
  trends and development, the underlying growth
  drivers and major issues faced by the industry
  are elicited. On the contention front, the market
  is personified by the intense competition in
  terms of research and development of novel
  therapeutic molecules. The leading players
  operating in the industry include Hologic,
  Johnson and Johnson, Siemens AG, Roche and
  Novartis which are also profiled in this report.

3
Breast cancer defines a malignant tumor that
has developed from cells in the breast

• The global oncology drugs market increased to
  US... billion in the year 2014, increasing from
  US.. billion in the year 2010 registering a CAGR
  of globally over the last five years.
• The U.S. has the maximum share in the drugs
  spending on cancer making of the total
  spending. In the European Union, oncology
  represents of total drug spending. Pharmerging
  countries had a share of in 2014. 
• The breast cancer drugs are estimated to
  contribute the maximum share of in 2014,
  followed by quantitative immunofluorescence with
  . A share of . was contributed by genomic
  analysis followed by IHC/FISH with a nominal
  share.
• For breast cancer in the U.S. are diagnosed at
  the local stage, .. are diagnosed at the
  regional stage, and .. are diagnosed at the
  distant level.

Global Oncology Drug Spending (2010-2014)
Global Breast Cancer Market by Segments (2014))
Global Oncology Spending by Region (2014)
4
Breast cancer is the most frequently diagnosed
cancer and the leading cause of cancer deaths in
women. ..
The U.S. Breast Imaging Systems Market
(2010-2016E)

• The breast imaging system market earned revenues
  of US.. billion in the year 2013 and is
  estimated to reach US.. billion by 2014 and
  further reach US.. billion by 2016 increasing
  at a CAGR of . 
• Total units of Digital Mammography in the U.S.
  for the year 2014 were along with facilities
  where the total units increased by from the
  previous fiscal.
• The U.S. market for Digital Breast Tomosynthesis
  is expected to see a significant rise in the
  number of units sold, increasing at an impressive
  CAGR of between 2013 and 2020.
• The Brazilian breast cancer imaging market has
  grown from US...million in 2013 to US...
  million in 2014 and is further estimated to reach
  US... million by the end of 2015.

The U.S. Digital Mammography Market (2010-2014)
Brazils Breast Cancer Imaging Market (2011-2015E)
5
Ageing women are the high risk population for
breast cancer as they are highly vulnerable to
developing breast cancer due to hormonal
imbalance
APAC - Tomography Scanners per Million People
(2014)

• Japan had the highest number of tomography
  scanners per million populations, which stood at
  units for 2014, followed by Australia which had
  units in the APAC region.
• The Republic of Korea has the highest number of
  mammography units per million female population
  aged which stood at... units, followed by other
  countries such as Japan, New Zealand and
  Australia.
• The European market for breast imaging systems is
  estimated to have increased from US... million
  in 2013 to approximately US... billion in 2014
  and further increase to US... billion by the
  year 2020.
• Europes mammography market revenue is estimated
  to have reached US...million in the year 2014,
  from US... million in 2013.

APAC - MRI Units per Million People (2014)
The European Mammography Systems Market
(2013-2018E)
6
Contact Us
View Report Details
These are abridged and sanitized sample pages
from the comprehensive report on the Global
Breast Cancer Market . To know more about this
report or for any customized research
requirement, please contact the following
Koncept Analytics CS-36, Second Floor, Ansal
Plaza Vaishali, Ghaziabad, U.P. 201010 T.
91-120-4130959 C 91-9811715635
vikas_at_konceptanalytics.com
Vikas Gupta BD Manager
www.konceptanalytics.com